Thomas A Prohaska - Concepedia

Author

Thomas A Prohaska

University of California San Diego ORCID

Also Known As

Thomas A Prohaska, Thomas A. Prohaska, Thomas A. Prohaska (318807)

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Medical University of Vienna Brigham and Women's Hospital Ionis Pharmaceuticals (United States)Carter Center

About

Thomas A Prohaska is an author at University of California San Diego specializing in medicine, pathology, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	674
2	Biochemistry	2	2	543
3	Health Sciences	1	1	42
4	Natural Sciences	1	1	22
5	Allergy	1	1	109

Thomas A Prohaska

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice Xuchu Que, Ming‐Yow Hung, Calvin Yeang, Nature OxysterolBiochemistryHyperlipidemiaHypercholesterolaemic MiceMedicine	2018	501
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome Erik S G Stroes, Veronica J Alexander, Ewa Karwatowska‐Prokopczuk, New England Journal of Medicine	2024	183
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk Brian A. Bergmark, Nicholas Marston, Thomas A Prohaska, New England Journal of Medicine	2024	159
B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis Sam Rosenfeld, Heather M. Perry, Ayelet Gonen, Circulation Research	2015	138
Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance Daniel B. Harmon, Prasad Srikakulapu, Jennifer L. Kaplan, Arteriosclerosis Thrombosis and Vascular Biology	2016	115
Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies Dimitrios Tsiantoulas, Thomas Perkmann, Taras Afonyushkin, Journal of Lipid Research Oxidation-specific EpitopesImmunologyPathologyImmunophenotypingExtracellular Microvesicles	2014	109
Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies Thomas A Prohaska, Xuchu Que, Cody J. Diehl, The Journal of Immunology	2018	46
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia Thomas A Prohaska, Veronica J. Alexander, Ewa Karwatowska‐Prokopczuk, Journal of clinical lipidology PathologyHyperlipidemiaPharmacotherapyFatty Liver DiseaseAbsolute Hff	2023	42
Targeting <i>APOC3</i> with Olezarsen in Moderate Hypertriglyceridemia Brian A. Bergmark, Nicholas Marston, Thomas A Prohaska, New England Journal of Medicine	2025	24
Systematic analysis of naturally occurring insertions and deletions that alter transcription factor spacing identifies tolerant and sensitive transcription factor pairs Zeyang Shen, Rick Z. Li, Thomas A Prohaska, eLife GeneticsAlter Transcription FactorGenomic MechanismMolecular BiologyMolecular Genetics	2022	22

Page 1